314 related articles for article (PubMed ID: 23175560)
1. Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and wales.
Ladhani SN; Andrews NJ; Waight P; Borrow R; Slack MP; Miller E
Clin Infect Dis; 2013 Mar; 56(5):633-40. PubMed ID: 23175560
[TBL] [Abstract][Full Text] [Related]
2. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.
Miller E; Andrews NJ; Waight PA; Slack MP; George RC
Lancet Infect Dis; 2011 Oct; 11(10):760-8. PubMed ID: 21621466
[TBL] [Abstract][Full Text] [Related]
3. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
4. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.
Poehling KA; Talbot TR; Griffin MR; Craig AS; Whitney CG; Zell E; Lexau CA; Thomas AR; Harrison LH; Reingold AL; Hadler JL; Farley MM; Anderson BJ; Schaffner W
JAMA; 2006 Apr; 295(14):1668-74. PubMed ID: 16609088
[TBL] [Abstract][Full Text] [Related]
5. Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.
Andrews NJ; Waight PA; George RC; Slack MP; Miller E
Vaccine; 2012 Nov; 30(48):6802-8. PubMed ID: 23000122
[TBL] [Abstract][Full Text] [Related]
6. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.
van der Linden M; Weiß S; Falkenhorst G; Siedler A; Imöhl M; von Kries R
Vaccine; 2012 Aug; 30(40):5880-5. PubMed ID: 22771186
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.
Rudnick W; Liu Z; Shigayeva A; Low DE; Green K; Plevneshi A; Devlin R; Downey J; Katz K; Kitai I; Krajden S; Ostrowska K; Richardson D; Richardson S; Sarabia A; Silverman M; Simor AE; Tyrrell G; McGeer A;
Vaccine; 2013 Dec; 31(49):5863-71. PubMed ID: 24099873
[TBL] [Abstract][Full Text] [Related]
8. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
[TBL] [Abstract][Full Text] [Related]
9. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
Hsu KK; Shea KM; Stevenson AE; Pelton SI;
Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
[TBL] [Abstract][Full Text] [Related]
10. Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010.
Lamb KE; Flasche S; Diggle M; Inverarity D; Greenhalgh D; Jefferies JM; Smith A; Edwards GF; Denham B; McMenamin J; McDonald E; Mitchell TJ; Clarke SC; Robertson C
Vaccine; 2014 Jul; 32(34):4356-63. PubMed ID: 23806244
[TBL] [Abstract][Full Text] [Related]
11. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
Isaacman DJ; McIntosh ED; Reinert RR
Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine.
Miller E; Andrews NJ; Waight PA; Slack MP; George RC
Vaccine; 2011 Nov; 29(49):9127-31. PubMed ID: 21983361
[TBL] [Abstract][Full Text] [Related]
13. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.
van Hoek AJ; Sheppard CL; Andrews NJ; Waight PA; Slack MP; Harrison TG; Ladhani SN; Miller E
Vaccine; 2014 Jul; 32(34):4349-55. PubMed ID: 24657717
[TBL] [Abstract][Full Text] [Related]
15. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956
[TBL] [Abstract][Full Text] [Related]
16. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.
Ingels H; Rasmussen J; Andersen PH; Harboe ZB; Glismann S; Konradsen H; Hoffmann S; Valentiner-Branth P; Lambertsen L;
Vaccine; 2012 Jun; 30(26):3944-50. PubMed ID: 22504662
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2010 Jul; 126(1):186-90. PubMed ID: 20498180
[TBL] [Abstract][Full Text] [Related]
18. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
Ingels HA
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
[TBL] [Abstract][Full Text] [Related]
19. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
Kellner JD; Vanderkooi OG; MacDonald J; Church DL; Tyrrell GJ; Scheifele DW
Clin Infect Dis; 2009 Jul; 49(2):205-12. PubMed ID: 19508165
[TBL] [Abstract][Full Text] [Related]
20. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.
Pilishvili T; Lexau C; Farley MM; Hadler J; Harrison LH; Bennett NM; Reingold A; Thomas A; Schaffner W; Craig AS; Smith PJ; Beall BW; Whitney CG; Moore MR;
J Infect Dis; 2010 Jan; 201(1):32-41. PubMed ID: 19947881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
